MENU

03.10.20

Daylights Saving and the Coronavirus Causing a Significant Impact on Sleep

  • KEYWORDS:
  • Excessive daytime sleepiness
  • Sleep

Lack of sleep from daylight savings time affects productivity, work performance, concentration, and memory, according to physicians at the University of Washington. The coronavirus may further affect sleep with the ongoing fear and uncertainty associated with this rapidly evolving situation. 

The Sleep Foundation reports that about 1 in 3 American adults don't get sufficient sleep on a regular basis. Lack of sleep impedes critical thinking abilities, making the ability to focus and pay attention difficult. This affects work performance and productivity. The impact of sleep loss on the economy is staggering as well. Sleep loss causes up to $411 billion in economic losses and about 1.23 million lost working days a year, according to a RAND Corporation study.

Of all the eMindful's eM Life participants, 54% have improved their sleep through the evidence-based applied programs. The collection is designed for daily use and includes applied mindfulness practices that can be integrated into everyday life. 

eMindful, the leading provider of purpose-driven mindfulness solutions with proven outcomes, has launched new Mindful Sleep Meditations to help with sleep loss from daylight savings and the concern over the Coronavirus. A study published in the Journal of the American Medical Association found that mindfulness meditation can help with insomnia and fatigue.

"The fatigue and daytime sleepiness that comes with losing sleep around daylight savings time and the coronavirus affects well-being and makes it difficult to perform at your best. This takes a toll on our nation's workforce and the economy," said Denise Shields, PhD, director of Curriculum, Delivery, and Research, eMindful. "Our sleep meditations, which are designed to relax the body and mind, prevent additional sleep loss and improve quality of sleep."
 

Virtual Reality System for Use During Stroke Recovery

Previous News Article

Nilvadipine Slowed Cognitive Decline in Early- but not Late-Stage Alzheimer Disease in Clinical Trial Post Hoc Analysis

Next News Article
This Month's Issue
Autoimmune Movement Disorders in Children

Monideep Dutt, MD; Jamika Hallman-Cooper, MD; Ekta Bery, MD; Mohammed Shahnawaz, MD; and Grace Gombolay, MD

Stiff-Person Syndrome

Jakai D. Nolan, DO, MPH, and Jacqueline A. Nicholas, MD, MPH

Smart Business Great Medicine: Care Flow

James Geyer, MD, and Paul Cox